These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 36794121)

  • 1. Double-Positive Anti-Glomerular Basement Membrane Antibody and Myeloperoxidase Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis Post COVID-19 mRNA vaccine: A Case Series of 4 Patients.
    Ting JA; Barbir EB; McRae SA; Schachter M; De Luca L; Riazy M; Levin A
    Can J Kidney Health Dis; 2023; 10():20543581231153217. PubMed ID: 36794121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systematic Review of Perinuclear Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis Following Coronavirus Disease 2019 Vaccination: A 2024 Update.
    Ogieuhi IJ; Suman F; Kumari N; Manita B; Kumari D; Devi J; Abdalla M; Shabbo E; Patel U; Samreen I; Mohamed KH; Ahmed Z; Nasir H
    Cureus; 2024 Apr; 16(4):e59390. PubMed ID: 38817489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-glomerular Basement Membrane Disease Concomitant with MPO-ANCA Positivity Concurrent with High Serum Levels of Interleukin-26 Following Coronavirus Disease 2019 Vaccination.
    Kobayashi S; Fugo K; Hatano R; Yamazaki K; Morimoto C; Terawaki H
    Intern Med; 2023 Apr; 62(7):1043-1048. PubMed ID: 36725042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of rapidly progressive glomerulonephritis with double-positive anti-GBM antibody and MPO-ANCA after SARS-CoV-2 vaccination and relapse during 1 year follow-up.
    Terakawa K; Niikura T; Katagiri D; Sugita A; Kikuchi T; Hayashi A; Suzuki M; Takano H
    CEN Case Rep; 2024 Feb; 13(1):19-25. PubMed ID: 37103638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual myeloperoxidase-antineutrophil cytoplasmic antibody- and antiglomerular basement membrane antibody-positive cases associated with prior pulmonary fibrosis: a report of four cases.
    Nakabayashi K; Fujioka Y; Nagasawa T; Kimura T; Kojima K; Arimura Y; Yamada A
    Clin Exp Nephrol; 2011 Apr; 15(2):226-34. PubMed ID: 21246240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A child with crescentic glomerulonephritis following SARS-CoV-2 mRNA (Pfizer-BioNTech) vaccination.
    Kim S; Jung J; Cho H; Lee J; Go H; Lee JH
    Pediatr Nephrol; 2023 Jan; 38(1):299-302. PubMed ID: 35854121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis as a Possible Side Effect of COVID-19 Vaccination.
    Noel E; Rashid U; Rabbani R; Khan WA; Benjamin YS; Lee I
    Cureus; 2022 Oct; 14(10):e30565. PubMed ID: 36415412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Case Report: MPO-ANCA Associated Vasculitis After Pfizer-BioNTech COVID-19 mRNA Vaccination].
    Mazza F; Cicciarelli A; Rubino F; Leopizzi M; Di Maio V; Cerbelli B; Tatangelo P; Palumbo R; Cioffi EA; Simonelli R
    G Ital Nefrol; 2023 Aug; 40(4):. PubMed ID: 37910213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
    Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
    Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of progressive systemic sclerosis with crescentic glomerulonephritis associated with myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) and anti-glomerular basement membrane antibody (anti-GBM Ab)].
    Kobayashi M; Saito M; Minoshima S; Arimura Y; Nagasawa T
    Nihon Jinzo Gakkai Shi; 1995 Mar; 37(3):207-11. PubMed ID: 7731110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of rapidly progressive glomerulonephritis associated with both antineutrophil cytoplasmic antibody-associated vasculitis and anti-glomerular basement membrane nephritis in the course of nontuberculous mycobacterium infection: a case report.
    Kato M; Wakiya R; Kameda T; Inoue K; Sofue T; Ushio Y; Sugihara K; Nakashima S; Shimada H; Mansour MMF; Kadowaki N; Dobashi H
    BMC Rheumatol; 2020 Dec; 4(1):68. PubMed ID: 33308324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case Report: ANCA-Associated Vasculitis Presenting With Rhabdomyolysis and Pauci-Immune Crescentic Glomerulonephritis After Pfizer-BioNTech COVID-19 mRNA Vaccination.
    Hakroush S; Tampe B
    Front Immunol; 2021; 12():762006. PubMed ID: 34659268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary renal syndrome in a child with coexistence of anti-neutrophil cytoplasmic antibodies and anti-glomerular basement membrane disease: case report and literature review.
    Bogdanović R; Minić P; Marković-Lipkovski J; Stajić N; Savić N; Rodić M
    BMC Nephrol; 2013 Mar; 14():66. PubMed ID: 23517575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.
    Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T
    Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of Anti-Glomerular Basement Membrane Antibodies and Myeloperoxidase Anti-Neutrophilic Cytoplasmic Antibodies in a Case of Rapidly Progressive Glomerulonephritis.
    Mavani GP; Pommier M; Win S; Michelis MF; Rosenstock J
    Front Med (Lausanne); 2015; 2():53. PubMed ID: 26301224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A relapsing case of pulmonary-renal syndrome after a sequential rise in MPO-ANCA and anti-GBM antibodies.
    Hoshino A; Sakairi T; Kayakabe K; Baba M; Ando M; Kimura H; Motohashi R; Nojima Y; Hiromura K
    CEN Case Rep; 2019 Aug; 8(3):221-225. PubMed ID: 30945174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case Report of MPO-ANCA-Associated Vasculitis Following Heterologous mRNA1273 COVID-19 Booster Vaccination.
    Kim BC; Kim HS; Han KH; Han SY; Jo HA
    J Korean Med Sci; 2022 Jul; 37(26):e204. PubMed ID: 35790206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De-novo Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Following the mRNA-1273 (Moderna) Vaccine for COVID-19.
    Feghali EJ; Zafar M; Abid S; Santoriello D; Mehta S
    Cureus; 2021 Nov; 13(11):e19616. PubMed ID: 34956751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study.
    Yoo BW; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Rheumatol; 2020 Mar; 39(3):831-840. PubMed ID: 31802348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients.
    Hu X; Shen C; Meng T; Ooi JD; Eggenhuizen PJ; Zhou YO; Luo H; Chen JB; Lin W; Gong Y; Xiong Q; Xu J; Liu N; Xiao X; Tang R; Zhong Y
    Front Immunol; 2022; 13():991469. PubMed ID: 36389826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.